These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 28483374

  • 1. 18F-FDG PET/CT in the clinical management of patients with lymphoma.
    Tamayo P, Martín A, Díaz L, Cabrero M, García R, García-Talavera P, Caballero D.
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):312-321. PubMed ID: 28483374
    [Abstract] [Full Text] [Related]

  • 2. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
    Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance, Australasian Leukaemia and Lymphoma Group, Eastern Cooperative Oncology Group, European Mantle Cell Lymphoma Consortium, Italian Lymphoma Foundation, European Organisation for Research, Treatment of Cancer/Dutch Hemato-Oncology Group, Grupo Español de Médula Ósea, German High-Grade Lymphoma Study Group, German Hodgkin's Study Group, Japanese Lymphorra Study Group, Lymphoma Study Association, NCIC Clinical Trials Group, Nordic Lymphoma Study Group, Southwest Oncology Group, United Kingdom National Cancer Research Institute.
    J Clin Oncol; 2014 Sep 20; 32(27):3059-68. PubMed ID: 25113753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Update on the use of FDG-PET/CT in malignant lymphoma].
    Terauchi T.
    Rinsho Ketsueki; 2016 Sep 20; 57(10):2008-2012. PubMed ID: 27795508
    [Abstract] [Full Text] [Related]

  • 5. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
    McCarten KM, Nadel HR, Shulkin BL, Cho SY.
    Pediatr Radiol; 2019 Oct 20; 49(11):1545-1564. PubMed ID: 31620854
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor.
    Dercle L, Seban RD, Lazarovici J, Schwartz LH, Houot R, Ammari S, Danu A, Edeline V, Marabelle A, Ribrag V, Michot JM.
    J Nucl Med; 2018 Jan 20; 59(1):15-24. PubMed ID: 28596157
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FDG-PET/CT in lymphoma.
    Juweid ME.
    Methods Mol Biol; 2011 Jan 20; 727():1-19. PubMed ID: 21331925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC).
    Fallanca F, Alongi P, Incerti E, Gianolli L, Picchio M, Kayani I, Bomanji J.
    Eur J Nucl Med Mol Imaging; 2016 Sep 20; 43(10):1837-48. PubMed ID: 27154522
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current Role of Functional Imaging in the Management of Lymphoma.
    Cheson BD, Meignan M.
    Curr Oncol Rep; 2021 Nov 04; 23(12):144. PubMed ID: 34735647
    [Abstract] [Full Text] [Related]

  • 16. Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission.
    Morbelli S, Capitanio S, De Carli F, Bongioanni F, De Astis E, Miglino M, Verardi MT, Buschiazzo A, Fiz F, Marini C, Pomposelli E, Sambuceti G.
    Eur J Nucl Med Mol Imaging; 2016 Feb 04; 43(2):232-239. PubMed ID: 26283504
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
    Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, Bisi G.
    Q J Nucl Med Mol Imaging; 2008 Mar 04; 52(1):9-16. PubMed ID: 18235420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. FDG-PET/CT in the management of lymphomas: current status and future directions.
    El-Galaly TC, Villa D, Gormsen LC, Baech J, Lo A, Cheah CY.
    J Intern Med; 2018 Oct 04; 284(4):358-376. PubMed ID: 29989234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.